Immunogenic and Protective Features of the Recombinant Vaccinia Virus Strain Expressing Cassette of Genes of Marburg Virus Structural Proteins

Immunogenic and Protective Features of the Recombinant Vaccinia Virus Strain Expressing Cassette of Genes of Marburg Virus Structural Proteins

The aim of the study was to create a highly immunogenic vaccine construct based on a recombinant variant of a replication-defective MVA strain of vaccinia virus, expressing virus-like particles that mimic natural infection with Marburg virus. Materials and methods. The recombinant virus was obtained...

Full description

Bibliographic Details
Main Authors:	A. V. Semenova, G. F. Sivolobova, A. A. Grazhdantseva, S. A. P’yankov, I. S. Shul’gina, O. S. Taranov, O. V. P’yankov, D. V. Antonets, L. I. Karpenko, E. V. Starostina, M. V. Borgoyakova, A. N. Chikaev, E. V. Gavrilova, R. A. Maksyutov, G. V. Kochneva
Format:	Article
Language:	Russian
Published:	Federal Government Health Institution, Russian Research Anti-Plague Institute “Microbe” 2022-01-01
Series:	Проблемы особо опасных инфекций
Subjects:	mva strain of vaccinia virus virus-like particles (vlp) marburg virus (marv) surface glycoprotein (gp) virion protein vp40 intracellular cytokine staining (ics)
Online Access:	https://journal.microbe.ru/jour/article/view/1604

Similar Items

Preparation of Class Y Immunoglobulins that Neutralize the Marburg Virus
by: O. A. Polezhaeva, et al.
Published: (2021-02-01)

Tanzania - The new habitat of Marburg virus
by: Fatema Hasan Kaifa, et al.
Published: (2023-06-01)

Development of an Immunochromatography Assay to Detect Marburg Virus and Ravn Virus
by: Katendi Changula, et al.
Published: (2023-11-01)

Experimental Vaccines for Prevention of Marburg Hemorrhagic Fever and Animal Models for Studying Pathogenesis
by: N. V. Volkova, et al.
Published: (2018-10-01)

A Cloned Recombinant Vesicular Stomatitis Virus-Vectored Marburg Vaccine, PHV01, Protects Guinea Pigs from Lethal Marburg Virus Disease
by: Wenjun Zhu, et al.
Published: (2022-06-01)

Natural History of Marburg Virus Infection to Support Medical Countermeasure Development
by: Jason E. Comer, et al.
Published: (2022-10-01)

Marburg virus is nature's wake-up call: A bird's-eye view
by: Sanjit Boora, et al.
Published: (2024-06-01)

Transcriptional profiling of immune responses in NHPs after low-dose, VSV-based vaccination against Marburg virus
by: Cecilia A. Prator, et al.
Published: (2023-12-01)

Obtaining Recombinant Antigens for the Development of Serological Diagnosis of Marburg Fever
by: N. V. Volkova, et al.
Published: (2021-02-01)

Marburg Virus and Monkeypox Virus: The Concurrent Outbreaks in Ghana and the lesson learned from the Marburg Virus Containment
by: Ranjit Sah, et al.
Published: (2022-12-01)

Development of a T7-Independent MARV Minigenome System
by: Bert Vanmechelen, et al.
Published: (2020-06-01)

Etymologia: Marburg Virus
by: Ronnie Henry, et al.
Published: (2017-10-01)

Vaccines against Ebola virus and Marburg virus: recent advances and promising candidates
by: John J. Suschak, et al.
Published: (2019-10-01)

Postexposure Treatment of Marburg Virus Infection
by: Thomas W. Geisbert, et al.
Published: (2010-07-01)

Ebola and Marburg virus matrix layers are locally ordered assemblies of VP40 dimers
by: William Wan, et al.
Published: (2020-10-01)

Recent outbreak of Marburg virus disease: Could it be a threat for global public health?
by: Md. Sohan, et al.
Published: (2023-01-01)

Marburg virus and the disease it causes
by: Vladimir A. Markin
Published: (2022-12-01)

A rabies virus-vectored vaccine expressing two copies of the Marburg virus glycoprotein gene induced neutralizing antibodies against Marburg virus in humanized mice
by: Jinhao Bi, et al.
Published: (2023-12-01)

Adapting Simon’s Two-Stage Design for Efficient Screening of Filovirus Vaccines in Non-Human Primates
by: Nancy A. Niemuth, et al.
Published: (2022-07-01)

Marburg and Ebola Virus Infections Elicit a Complex, Muted Inflammatory State in Bats
by: Anitha D. Jayaprakash, et al.
Published: (2023-01-01)

Development of the Multiplex Real-Time PCR for Marburg, Ebola, and Lassa Viruses Identification
by: A. O. Sementsova, et al.
Published: (2011-06-01)

Marburg Virus VP30 Is Required for Transcription Initiation at the Glycoprotein Gene
by: Megan R. Edwards, et al.
Published: (2022-10-01)

Studies of Reservoir Hosts for Marburg Virus
by: Robert Swanepoel, et al.
Published: (2007-12-01)

MONOCLONAL ANTIBODIES AND RECOMBINANT PROTEINS OF FILOVIRUSES: IMMUNOCHEMICAL PROPERTIES AND EVALUATION OF THEIR EFFICIENCY FOR IMMUNE DIAGNOSTICS OF MARBURG AND EBOLA VIRUSES
by: E. I. Kazachinskaia, et al.
Published: (2014-07-01)

Assays for the Evaluation of the Immune Response to Marburg and Ebola Sudan Vaccination—Filovirus Animal Nonclinical Group Anti-Marburg Virus Glycoprotein Immunoglobulin G Enzyme-Linked Immunosorbent Assay and a Pseudovirion Neutralization Assay
by: Thomas L. Rudge, et al.
Published: (2022-07-01)

Comparison of Aerosol Stability of Different Variants of Ebola Virus and Marburg Virus and Virulence of Aerosolised Ebola Virus in an Immune-Deficient Mouse
by: Sophie J. Smither, et al.
Published: (2022-04-01)

Mutation of Hydrophobic Residues in the C-Terminal Domain of the Marburg Virus Matrix Protein VP40 Disrupts Trafficking to the Plasma Membrane
by: Kaveesha J. Wijesinghe, et al.
Published: (2020-04-01)

Recombinant Protein Filovirus Vaccines Protect Cynomolgus Macaques From Ebola, Sudan, and Marburg Viruses
by: Axel T. Lehrer, et al.
Published: (2021-08-01)

Protection against Marburg Virus and Sudan Virus in NHP by an Adenovector-Based Trivalent Vaccine Regimen Is Correlated to Humoral Immune Response Levels
by: Machteld M. Tiemessen, et al.
Published: (2022-08-01)

Pathogenicity and virulence of Marburg virus
by: Mehedy Hasan Abir, et al.
Published: (2022-12-01)

Single Dose of a VSV-Based Vaccine Rapidly Protects Macaques From Marburg Virus Disease
by: Andrea Marzi, et al.
Published: (2021-10-01)

Shedding of Marburg Virus in Naturally Infected Egyptian Rousette Bats, South Africa, 2017
by: Janusz T. Pawęska, et al.
Published: (2020-12-01)

Micro‒Global Positioning Systems for Identifying Nightly Opportunities for Marburg Virus Spillover to Humans by Egyptian Rousette Bats
by: Brian R. Amman, et al.
Published: (2023-11-01)

Development of a Well-Characterized Cynomolgus Macaque Model of Marburg Virus Disease for Support of Vaccine and Therapy Development
by: Kendra J. Alfson, et al.
Published: (2022-08-01)

Marburg Virus Infection in Egyptian Rousette Bats, South Africa, 2013–2014
by: Janusz T. Pawęska, et al.
Published: (2018-06-01)

Host and Viral Proteins Modulating Ebola and Marburg Virus Egress
by: Tamsin B. Gordon, et al.
Published: (2019-01-01)

Previremic Identification of Ebola or Marburg Virus Infection Using Integrated Host-Transcriptome and Viral Genome Detection
by: Emily Speranza, et al.
Published: (2020-06-01)

Mining of Marburg Virus Proteome for Designing an Epitope-Based Vaccine
by: Mohamed A. Soltan, et al.
Published: (2022-07-01)

Emergence of Marburg virus: a global perspective on fatal outbreaks and clinical challenges
by: Shriyansh Srivastava, et al.
Published: (2023-09-01)

Retrospective Evaluation of Control Measures for Contacts of Patient with Marburg Hemorrhagic Fever
by: Aura Timen, et al.
Published: (2012-07-01)